ARTICLE | Finance
Flying Delta in Japan
Why Delta-Fly is only the third biotech to list in Japan in three years
September 21, 2018 10:23 PM UTC
That Delta-Fly Pharma Inc. is slated to become only the third biotech to go public on Tokyo Stock Exchange’s Mothers in three years is the latest reminder that tough listing standards are still making it an uphill battle for Japanese biotechs to list on their local exchange.
On Sept. 20, the cancer company announced plans to sell 700,000 shares at ¥4,570 to ¥4,770 per share. Delta-Fly plans to begin trading on Oct. 3. ...